Below is a summary of our recent news. Click any post title or the read more link below any story to see more!
Horizon Therapeutics has announced a short-term supply disruption for TEPEZZA (TM), a medication approved earlier this year for the treatment of thyroid eye disease.
UPDATE (Feb. 4th): Horizon Therapeutics has released a new FAQ regarding the supply disruption. Please note that this information is being provided as a service to our patient and physician community, and that specific questions should be directed to Horizon Patient Services at the number included in the FAQ.
Please join us for a Facebook Live Event on Thursday, Dec. 10th at 8:00 p.m. EST / 5:00 p.m. PST! To participate, visit https://facebook.com/theaaes. If you can't join us live, the content will be archived for later viewing.
To our valued community members,
If you are on Twitter, please join the GDATF, American Association of Endocrine Surgeons and the American Thyroid Association at 8:00 EST for tonight's #thyroidchat! This is a great opportunity to get your questions answered (in 280 characters or less). Simply log on to your account and search for the hashtag #thyroidchat.
If you missed Saturday's webinar on Thyroid Eye Disease, the program is now available on our YouTube channel! Huge thanks to Dr. Don Kikkawa, Dr. Kyle Godfrey, Dr. Suzanne Freitag, Dr. Bradford Lee, and to our special guest Carl for sharing his personal experience with TED.